Financial Daily from THE HINDU group of publications
Wednesday, Aug 03, 2005
Financial Daily from THE HINDU group of publications Wednesday, Aug 03, 2005 |
|
|
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures Relisys pact for clinical trials Our Bureau
HYDERABAD: Relisys Medical Devices Ltd, a Hyderabad-based stent and catheter manufacturer, has entered into an agreement with a German company to launch international clinical trials on a drug eluting stent that reduces tissue inflammation and reaction. Addressing a press conference here on Tuesday, Dr N Krishna Reddy, Chairman of the company, said the agreement with Blue Membranes GmbH would enhance the performance of the company's cobalt-chromium stent.
The animal trials for the carbon-carbon coated stent were completed at the Cardiovascular Research Institute at Washington. "Now multinational clinical trials would begin in countries such as India and Brazil. Spanning over 10-12 months, the trails would randomise 150 patients in nearly 15 centres," Dr Krishna Reddy said. The company's catheter facility would be ready by the year-end. The trial production was slated for January next.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|